| Bioactivity | YM-I-26 is a selective NLRP3 inflammasome inhibitor. YM-I-26 enhances the phagocytosis of β-amyloid protein by mouse microglial BV2 cells and inhibits the production of IL-1β and IL-10. YM-I-26 can be used to study the immunomodulatory activity associated with inflammation[1]. |
| CAS | 2585015-90-1 |
| Formula | C28H33ClN2O5S2 |
| Molar Mass | 577.16 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Biby S, et al. Functional Characterization of an Arylsulfonamide-Based Small-Molecule Inhibitor of the NLRP3 Inflammasome[J]. ACS Chemical Neuroscience, 2024. |
YM-I-26
CAS: 2585015-90-1 F: C28H33ClN2O5S2 W: 577.16
YM-I-26 is a selective NLRP3 inflammasome inhibitor. YM-I-26 enhances the phagocytosis of β-amyloid protein by mouse mi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.